Impact of Sinus Surgery on Individuals With Cystic Fibrosis
NCT04469439 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 170
Last updated 2026-04-22
Summary
This study will be a prospective, observational study of patients who undergo endoscopic sinus surgery for cystic fibrosis-related chronic rhinosinusitis (CRS). Individuals who do not undergo surgery but are treated medically for CRS will also be enrolled to serve as a control group. Outcomes analyzed will include pulmonary, quality of life, and others.
Conditions
- Chronic Rhinosinusitis (Diagnosis)
- Cystic Fibrosis
Sponsors & Collaborators
-
Cystic Fibrosis Foundation
collaborator OTHER -
University of California, Los Angeles
lead OTHER
Principal Investigators
-
Daniel M Beswick, MD · University of California, Los Angeles
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-01
- Primary Completion
- 2027-01-31
- Completion
- 2027-01-31
Countries
- United States
Study Locations
More Related Trials
-
Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease
NCT00934362 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients
NCT00004296 ·Status: COMPLETED
-
Airway Clearance Therapy on Hyperpolarized 129Xenon and MRI
NCT03593434 ·Status: COMPLETED
-
The Sinonasal Cavity as a Reservoir for Upper Airway Bacterial Development
NCT03016689 ·Status: COMPLETED
-
Assessment of CFTR-Modulator Treatment in Cystic Fibrosis Lung Disease Using Novel Structural and Functional MRI
NCT04391322 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of Triple Combination CFTR Therapy on Sinus Disease.
NCT04056702 ·Status: UNKNOWN
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis
NCT00506792 ·Status: COMPLETED ·Phase: PHASE2
-
Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation
NCT02591524 ·Status: UNKNOWN ·Phase: NA
-
Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents
NCT00758771 ·Status: COMPLETED
-
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease
NCT01973192 ·Status: COMPLETED
-
Manuka Honey Sinus Rinse Study
NCT04589897 ·Status: COMPLETED ·Phase: NA
-
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
NCT02109822 ·Status: COMPLETED
-
Timing of Hypertonic Saline Inhalation Relative to Airways Clearance in Cystic Fibrosis
NCT01753869 ·Status: TERMINATED ·Phase: NA
-
Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials
NCT04580368 ·Status: RECRUITING ·Phase: NA
-
Breath Condensate Study in Patients With Cystic Fibrosis.
NCT02056132 ·Status: COMPLETED
-
Glycemic Monitoring in Cystic Fibrosis
NCT02211235 ·Status: COMPLETED
-
The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis
NCT00271310 ·Status: COMPLETED ·Phase: PHASE3
-
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis
NCT01661491 ·Status: COMPLETED
-
COVID-19 Antibody Responses In Cystic Fibrosis
NCT04904445 ·Status: COMPLETED
-
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223 ·Status: TERMINATED
-
Airway Microbiome of Cystic Fibrosis Patients
NCT06057558 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis
NCT06413459 ·Status: RECRUITING
-
Regional Monitoring of CF Lung Disease
NCT06339593 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs
NCT00590330 ·Status: COMPLETED
-
Action of Epigenetic Modifiers in Cystic Fibrosis Treatment
NCT01883284 ·Status: COMPLETED ·Phase: NA